Farahnak Assadi to Phosphodiesterase 5 Inhibitors
This is a "connection" page, showing publications Farahnak Assadi has written about Phosphodiesterase 5 Inhibitors.
Connection Strength
0.523
-
Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus. Am J Nephrol. 2015; 42(1):65-9.
Score: 0.523
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.